Data updated: Mar 29, 2026

RECORDATI RARE

Pharmaceuticals

Big Pharma

RECORDATI RARE is a major pharmaceutical company with 12 FDA-approved products.

1949

Since

12

Drugs

-

Trials

9

Approved (2yr)

Key Drugs

osilodrostat phosphate

CYP11B1 2 indications · 2020

cysteamine hydrochloride

2 indications · 2020

pasireotide diaspartate

SSTR1 1 indications · 2012

SIGNIFOR LAR KIT

pasireotide pamoate

Top Drug Revenues ProEarly access

Loading...

Revenue Over Time ProEarly access

Loading...

Competitive Matchups ProEarly access

Loading...

Recent Activity

ISTURISA 2025-11-04

Manufacturing (CMC)

ISTURISA 2025-07-03

ISTURISA 2025-04-15

INDOCIN 2024-11-21

INDOCIN 2024-11-21

INDOCIN 2024-11-21

CHEMET 2024-09-16

SIGNIFOR 2024-07-11

SEC Filings ProEarly access

Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Forecast

Loading...

Upcoming Trial Milestones ProEarly access

Loading...

Patent Cliff ProEarly access

Loading...